It has been discovered that the antitumor effect of combining sorafenib (an antitumor drug) with type 1 interferon (an antiviral drug) in liver cancer treatment is enhanced (Associate Professor Hirayuki Enomoto, Department of Internal Medicine, Hepatology, Gallbladder, and Pancreas)